{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T20:14:00Z","timestamp":1789330440093,"version":"build-2803163510"},"reference-count":21,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2017,9,12]]},"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>As proof of concept, this prospective, observational study assessed the feasibility and early clinical outcomes of performing on-pump cardiac surgery with the RenalGuard system.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Acute kidney injury (AKI) is reported in up to 30% of patients undergoing cardiac surgery and is a recognised independent predictor of both morbidity and mortality. Forced diuresis with the RenalGuard system reduces the incidence of AKI during percutaneous coronary intervention procedures but its use in cardiac surgery has not been explored.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Ten consecutive patients who were at risk of developing AKI during cardiac surgery were selected. The RenalGuard system was used to facilitate forced diuresis using weight-adjusted intravenous furosemide while maintaining neutral fluid balance by matched intravenous fluid replacement. This regimen was initiated preoperatively in all patients and continued for 6\u201312\u2009hours postoperatively. Serum creatinine, electrolytes and need for renal replacement were documented in all patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The RenalGuard system functioned successfully in all patients and facilitated high perioperative urine outputs, even when patients were placed on cardiopulmonary bypass (CPB). There were no incidences of significant (A) electrolyte imbalance, (B) changes in haemoglobin levels or (C) pulmonary oedema. No patients developed AKI within 36\u2009hours of surgery despite one patient developing cardiac tamponade 8\u2009hours postoperatively and one patient developing paralytic ileus. One patient, however, was \u2018electively\u2019 haemofiltered on day 2 after developing acute right ventricular failure. The median intensive care stay was 1.5 (1, 5) days.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The RenalGuard system can be used successfully in patients undergoing cardiac surgery with CPB and may reduce the incidence of AKI in at-risk patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration<\/jats:title>\n                  <jats:p>NCT02974946; Pre-results.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2017-000669","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T20:10:13Z","timestamp":1507666213000},"page":"e000669","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["The use of the RenalGuard system in cardiac surgery with cardiopulmonary bypass: a first in man prospective, observational, feasibility pilot study"],"prefix":"10.1136","volume":"4","clinical-trial-number":[{"clinical-trial-number":"nct02974946","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1218-1243","authenticated-orcid":false,"given":"Heyman","family":"Luckraz","sequence":"first","affiliation":[{"name":"Department of Cardiothoracic Surgery, Heart & Lung Centre, Wolverhampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Giri","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Anaesthesiology, Heart & Lung Centre, Wolverhampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benmjamin","family":"Wrigley","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart & Lung Centre, Wolverhampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Hennessy","sequence":"additional","affiliation":[{"name":"Department of Clinical Perfusion, Heart & Lung Centre, Wolverhampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Nicholas","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Heart & Lung Centre, Wolverhampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Nevill","sequence":"additional","affiliation":[{"name":"University of Wolverhampton, Wolverhampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,10,10]]},"reference":[{"key":"2025081710483058000_4.2.e000669.1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1051\/ject\/201547016","article-title":"Acute kidney injury subsequent to cardiac surgery","volume":"47","author":"Kramer","year":"2015","journal-title":"JECT"},{"key":"2025081710483058000_4.2.e000669.2","doi-asserted-by":"publisher","DOI":"10.1186\/cc2872"},{"key":"2025081710483058000_4.2.e000669.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17831-3"},{"key":"2025081710483058000_4.2.e000669.4","doi-asserted-by":"publisher","DOI":"10.1186\/cc5713"},{"key":"2025081710483058000_4.2.e000669.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2005.01.057"},{"key":"2025081710483058000_4.2.e000669.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2008.04.017"},{"key":"2025081710483058000_4.2.e000669.7","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivu276.61"},{"key":"2025081710483058000_4.2.e000669.8","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2015.07.013"},{"key":"2025081710483058000_4.2.e000669.9","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1186\/cc12491","article-title":"The effect of acute kidney injury on long-term health-related quality of life: a prospective follow-up study","volume":"17","author":"Hofhuis","year":"2013","journal-title":"Crit Care"},{"key":"2025081710483058000_4.2.e000669.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(99)01298-9"},{"key":"2025081710483058000_4.2.e000669.11","first-page":"499","article-title":"Furosemide infusion prevents the requirement of renal replacement therapy after cardiac surgery","volume":"9","author":"Kunt","year":"2009","journal-title":"Anadolu Kardiyol Derg"},{"key":"2025081710483058000_4.2.e000669.12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1681\/ASN.V11197","article-title":"Lack of renoprotective effects of dopamine and furosemide during cardiac surgery","volume":"11","author":"Lassnigg","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"2025081710483058000_4.2.e000669.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00574-9"},{"key":"2025081710483058000_4.2.e000669.14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.111.961391"},{"key":"2025081710483058000_4.2.e000669.15","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.03.024"},{"key":"2025081710483058000_4.2.e000669.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2011.08.017"},{"key":"2025081710483058000_4.2.e000669.17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.030759"},{"key":"2025081710483058000_4.2.e000669.18","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.jcin.2015.07.012","article-title":"Acute kidney injury with the RenalGuard system in patients undergoing transcatheter aortic valve replacement. The PROTECT-TAVI trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation)","volume":"8","author":"Barbanti","year":"2015","journal-title":"J Am Coll Cardiol Intv"},{"key":"2025081710483058000_4.2.e000669.19","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000079785.13922.F6"},{"key":"2025081710483058000_4.2.e000669.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2007.12.030"},{"key":"2025081710483058000_4.2.e000669.21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040296","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2017-000669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T17:48:38Z","timestamp":1755452918000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2017-000669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,10,10]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1136\/openhrt-2017-000669"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2017-000669","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}